• Company
• Pricing negotiations for Koselugo’s reimb start after 2 yrs
• by Eo, Yun-Ho Oct 11, 2023 05:36am

• Company
• Trajenta, unregistered patent challenge spreads
• by Kim, Jin-Gu Oct 10, 2023 05:27am

• Policy
• Tepmetko attempts reimb again in KOR
• by Lee, Tak-Sun Oct 10, 2023 05:27am

• Company
• Disadvantages of effective ADC anticancer drugs
• by Oct 10, 2023 05:27am

• Company
• GSK’s momelotinib receives orphan drug designation in KOR
• by Eo, Yun-Ho Oct 10, 2023 05:26am

• Company
• Hemgenix receives orphan drug designation in KOR
• by Eo, Yun-Ho Oct 10, 2023 05:26am

• Policy
• Will Leclaza also begin drug price negotiations soon?
• by Lee, Tak-Sun Oct 10, 2023 05:26am

• Company
• Dongkook succeeds P3T for its BPH combination drug
• by Chon, Seung-Hyun Oct 6, 2023 05:37am

• Policy
• Pfizer applies for reimb of its COVID-19 Tx Paxlovid
• by Lee, Tak-Sun Oct 6, 2023 05:36am

• Product
• Investigation into companies refusing to supply animal med.
• by Kim JiEun Oct 6, 2023 05:36am